chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Additional Details: pt received vaccine was sitting in chair talking after 10 minutes, but by 15 minutes he looked like he was sleeping but was unresponsive. breathing fine but unresponsive. right hand looked distorted and he kept yawning. called 911.  by the time they arrived he was talking fine. EMS concluded he had reaction also ekg showed  Left bundle branch block. refused to go in ambulance, advised to follow up with md.
Initial and follow up information has been received from a licensed practical nurse through a company representative concerning a 37 year old white male state systems analyst with asthma, sleep apnea, and no known allergies who on 1/24/05 was vaccinated IM in the left deltoid with a 0.5ml first dose of pneumococcal 23v polysaccharide vaccine (lot # 649912/0529P) at approximately 4:00 PM. Concomitant therapies included montelukast sodium, fluticasone propionate, albuterol and guaifenesin/pseudoephedrine HCL. There was no illness at the time of vaccination. On 1/25/05 the patient developed redness, swelling, and pain and warmth at the site of injection. The swelling and redness increased and radiated down to his hand and thumb in the vaccinated arm with increasing pain. It was also reported that the patient was treated with amoxicillin (+) clavulanate potassium and diphenhydramine hydrochloride, acetaminophen (+) diphenhydramine hydrochloride and cold packs. It was reported that the patient refused to go to the emergency room or RTC. The patient was reported to be recovered on 2/1/05. It was also reported that it was unknown if the patient had a previous dose of pneumococcal 23v polysaccharide vaccine. The reporter considered the patient's experiences to be a medically important event (OMIC). Additional information has been requested.
Please also see Covid Vaccine #2 report of 5/21/2021 (I am SURE of the date on that report). I checked repeatedly at my house on Street to make sure the proper number of weeks had transpired before getting dose #2.  Same auditory, exactly. See description in COVID Vaccine #2, of 5/21/2021.  Maybe, I looked within my mind to see if there were visuals accompanying. Not sure if I created a visual  to represent the sounds, in order to remember them and describe them, or if the visuals, colors, linear and curved, three dimensional, with texture, were a result of something I was trying to see and actually saw when I allowed myself to the ability to see "into" that part of my brain where the auditory was coming from.  I think I saw the same colors, textures, etc., the COVID shot #2, but I didn't try as hard the first adverse auditory reaction to "see", as I did the second COVID shot #4, reported here.  I am familiar with, eclectic musical tastes, familiar with art/terminology/styles/colors, and cultures from many countries around the world.  My family includes professionals in engineering, science, military, coal mining/trucking, many types of factory work, and 2nd/3rd generation immigrants, language scant, but cultural understanding of family gets stronger with more reading and education.
muscle ache; fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): (Janssen).  A 52-year-old male patient received BNT162b2 (BNT162B2), on 01Apr2022 as dose 2 (booster), single (Batch/Lot number: unknown) at the age of 52 years intramuscular for covid-19 immunization; Janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), on 29Oct2021 as dose 1, single (Batch/Lot number: unknown) intramuscular for immunization. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: MYALGIA (non-serious), outcome "unknown", described as "muscle ache"; FATIGUE (non-serious), outcome "unknown".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This study case was received from the investigator on 23 April 2010. A 38 year-old male subject with a medical history significant for high blood pressure and elevated cholesterol received the following vaccines on 06 July 2009: ACAM2000 (lot number not reported.); TYPHIM VI (lot number not reported) and anthrax (manufacturer and lot number not reported). Eighteen days post vaccination the subject was diagnosed with acute pericarditis, unspecified. It was also reported that on 17 July 2009 the subject had an abnormal troponin (actual result was 00.81) and a normal electrocardiogram. No other information was provided. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
the day after vaccination she went home at 3pm feeling sleepy with chills and injection site warmth/pain
The first vaccination I felt feverish and achy with bad headache and my knuckles swelled. My second vaccination I begin having terrible (spiratic) Chest pain and back pain two days after and a headache and nausea followed. This had been going on along with racing heart and palpitations. I have since been hospitalized with all these symptoms on 11/20/2021. The only issue I had prior to the vaccination was High blood pressure which was well controlled.
Complaint of cough, chills, headache, runny nose/congestion, and myalgia
HPI: This is a 20 year old male presenting with chest pain since yesterday. Pain started gradually after receiving 3rd  COVID-19 booster shot. It is described as dull and aching, radiating into nowhere. Pain is described as moderate upon onset and is currently mild, with symptoms such as shortness of breath and heart palpitations.  No history of the same.
Patient report hives all over body, including on palms of hands.  Her hands also appeared slightly swollen.
large, diffuse local reaction including erythema, edema, tenderness, itching around whole deltoid area where injection was given
The upper right arm, from elbow to mid-arm, became bright red with fever, pain and itching.
Patient got a shingles rash on his abdomen, confirmed by a dermatologist and treated with Valtrex.
mom called clinic to report  pt lt arm was red & swollen took to MD & was poss allergy to vax, t97;
Could not sleep; Joint pain; Unable to walk that well; Intense itching in left deltoid; Body aches; Fatigue; Headache; Congestion; Sore throat; Injection site warm to touch; Slightly erythematous; Induration; Low grade fever 99.9; A spontanious report was received from other healthcare professional concerning a 38 Years old, female patient who injection site warmth, injection site erythema, injection site induration, pyrexia, pain, fatigue, headache, nasal congestion, oropharyngeal pain, injection site pruritus, gait disturbance, insomnia, arthralgia.   The patient's medical history was reported included chronic fatigue, COVID, depression, anxiety lupus. Current illness included allergies to oxycodone, sulfa and doxycycline. Concomitant medication reported included vyvansa, sertraline, folic acid, methotrexate, topiramate, hydrochloroquine.   On 22-Dec-2020, prior to the onset events patient received their first of two planned doses of mRNA-1273 (Batch number not provided) for prophylaxis of COVID-19 infection.    On 24-Dec-2020 patient experienced Injection site warm to touch, Slightly erythematous, Induration, Low grade fever 99.9, Body aches, Fatigue, Congestion, Sore throat. On 29-Dec-2020 patient experienced Intense itching in left deltoid. On 8-Jan-2021 experienced unable to walk that well. On an unknown date patient reported she could not sleep, joint pain, Intense itching in left deltoid. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events injection site warmth, injection site erythema, injection site induration, pyrexia, pain, fatigue, headache, nasal congestion, oropharyngeal pain, injection site pruritus, gait disturbance, insomnia, arthralgia was unknown.  Based on comment, (Injection site pruritus) is deleted
Initial report received on 6/15/06 from a health care professional. This is a 17 year old female patient who has a past medical history of orbital pseudotumor on 12/07/05 that resolved. The patient received a SC injection of Tubersol on 4/24/06 and a SC injection of Menactra on 4/18/06. The lot numbers and sites of administration were not reported for either products. It is not recommended that Menactra or Tubersol be administered SC. The patient developed an orbital pseudotumor 42 days after receiving Tubersol. She was subsequently treated with high doses of corticosteroids. Relevant tests and laboratory data were reported as normal. At the time of this report, the patient had recovered from these events. The patient experienced a previous orbital pseudotumor on 12/08/050 after vaccination with Adacel on 12/7/05. The patient recovered. This event is reported in case 200601477. (OMIC)
9/28/11 post injection experienced pain, aching, in arm with numbness in fingers, swelling at elbow, stated "fingers turned blue". Did not report this to the Health Unit until hours post injection. Client was offered ice pack, analgesic (refused med) offered BENADRYL, (refused) stated "will take BENADRYL at bed time." 9/29/11 woke up c/o neck, shoulder pain, hip pain bilateral, eyes swollen, elbow throbbing. Denies nausea, took ALEVE. 09/30/11 no symptoms, 10/03/11 recheck stated "it is fine".
A headache about 3 hours after receiving the shot which by the next day became a full migraine, chills and a temperature of 100.2.
Loss of taste; Headache; Swollen lymph nodes in throat and ears; Feeling very tired and exhausted; Very sore arm; This is a spontaneous report received from a contactable consumer, the patient. An adult non-pregnant female patient of unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 16Mar2021 at 10:45, as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, psoriasis, eczema, allergic rhinitis, high blood pressure and migraines. The patient was allergic to apremilast (OTEZLA), sulfasalazine (MANUFACTURER UNKNOWN), dairy, eggs and food preservatives. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) 10 mg, paracetamol (TYLENOL) 500 mg, loratadine (CLARITIN) 10 mg; all for unknown indications from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 00:00, the patient had very sore arm, headache, swollen lymph nodes in throat and ears, feeling very tired and exhausted. On 20Mar2021 (4 days later), the patient experienced loss of taste. The patient did not receive any treatment for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the sore arm, loss of taste, headache, swollen lymph nodes in throat and ears, feeling very tired and exhausted were not recovered.  Information on lot number has been requested.
This spontaneous report as received from a nurse and a healthcare worker refers to a 4 year old female patient. The patient's concurrent conditions, medical history and concomitant therapy were not provided. On 12-NOV-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck), lot # L030586 with an expiration date on 10-FEB-2017 (dose and route of administration were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
woke up in middle of night; Cold sweats; Chills; Soreness in arm of injection site; Lethargy; Dry mouth; Dose number: 1 (Pfizer Bivalent); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 at 09:15 as dose 1, single (Lot number: GH9702) at the age of 46 years, in left arm for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history included: "Bipolar disorder" (unspecified if ongoing); "Stents" (unspecified if ongoing), notes: stents of hypertension; "Hypertension" (unspecified if ongoing), notes: stents of hypertension. Concomitant medication(s) included: LISINOPRIL. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 11Oct2022 at 09:15, outcome "unknown", described as "Dose number: 1 (Pfizer Bivalent)"; CHILLS (non-serious) with onset 13Oct2022 at 02:00, outcome "recovered" (Oct2022); COLD SWEAT (non-serious) with onset 13Oct2022 at 02:00, outcome "recovered" (Oct2022), described as "Cold sweats"; DRY MOUTH (non-serious) with onset 13Oct2022 at 02:00, outcome "recovered" (Oct2022); LETHARGY (non-serious) with onset 13Oct2022 at 02:00, outcome "recovered" (Oct2022); VACCINATION SITE PAIN (non-serious) with onset 13Oct2022 at 02:00, outcome "recovered" (Oct2022), described as "Soreness in arm of injection site"; MIDDLE INSOMNIA (non-serious) with onset 13Oct2022 at 02:00, outcome "recovered" (Oct2022), described as "woke up in middle of night". Therapeutic measures were not taken as a result of middle insomnia, cold sweat, chills, vaccination site pain, lethargy, dry mouth.  Additional information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient woke up in middle of night with cold sweats chills and soreness in arm of injection site, lethargy, dry mouth. Patient did not receive other vaccine in four weeks. Other medications in two weeks included Lisinopril 10mg per day.
Dizziness/vertigo, nausea (started on 11/6 and has been present since tingly cheeks/chin/lips (started 11/16)  Emergency room  via ambulance on 11/8 due to extreme dizziness when driving - treated with fluids and antivert 25mg  and released. Had bloodwork, head ct, ekg - all normal   Saw Neurologist  11/10   PT- started 11/16
Acute pain of the left shoulder:  On November 17th, the patient had her flu vaccination. She does not watch when she gets injections, but when she got home she thought it was odd that her Band-Aid where she had gotten the injection was very high on her shoulder, almost at the complete angle of her shoulder. The injection she thought was a little more painful than typical, but as it was the high-dose flu, she had attributed it to that. After about two hours, she developed a lot of severe pain in the shoulder area. Over the next few days, this progressed to more generalized left shoulder pain.   inappropriately placed flu vaccination. She does have limitations and abnormalities on her examination. We discussed that our primary goals are to help her control her pain and resume usual function. I have prescribed physical therapy. Obtain MRI for joint assessment. See orthopedics for opinion on possible treatments. They may be familiar with this having happened before. I will institute an incident review and adverse event process. She is to follow-up with me after orthopedics if  he is not seeing any progress. It is okay for her to use Advil PM and Advil plain during the day as well as Tylenol to help mitigate her pain.
Patient is fully vaccinated. Patient tested positive Sunday 12/19/21. Patient presented with SOB, progressive dyspnea with exertion, dry cough and chills.  No fevers, chest pain, hemoptysis, lower extremity edema, abdominal pain, diarrhea, vomiting.  Patient hypoxic on arrival, with 88% SpO2 on room air. Respiratory failure from COVID-19 pneumonia. CXR: Bilateral infiltrates consistent with clinical history of Covid 19 infection, no evidence of PE.  She improved with supplemental oxygen, steroids, anticoagulation and antiviral therapy, remdesivir. She was discharged home once cleared by pulmonary and medically stable.
Pt assisted to waiting area immediately began to have hives, lightheaded and dizzy nurse with patient began assessment.  B/P 150/72 , HR 98-207 irregular - lungs CTA bilaterally.  While observing patient she c/o throat closing EPIPEN 0.3 mg IM given in right outer lateral thigh at 10:37 AM by nurse.  Pt remained alert and oriented EMS arrived report given patient transported to hospital for assessment.
Patient came into pharmacy on 1-16-10 to tell us he was experiencing pain and tingling in his right arm. He said this started shortly after his H1N1 vaccine on 12-31-09.
Thirst; Chills; Fever; Generalized muscle aches (with greater intensity in legs and back); tiredness; and pain, swelling, redness, and hardening in the arm (injection area).
Interstitial cystitis -  No flare up in years. Less than (1) week after 2nd SHOT. Severe flare, Req 6 weeks of treatment - did not help On different Interstitial cystitis website forums many others had serious flare-ups after many years without one.
Patient complaint of redness, puritis & edema of injection-site. patient currently at work, and we have not seen or assessed site yet. LVN
Patient states after getting her FLUZONE HD shot and PNEUMOVAX 23 shot on 9/22/17 at about 230pm she began to develop symptoms of nausea and vomiting around 8pm 9/22/17. She continued with terrible nausea and vomiting and extreme fatigue for 3-4 days and only starting feeling better 9/26/17. She reports fatigue to the extent she had an episode of urinary incontinence. She was advised the shots really cannot cause illness, but she was sure this reaction was secondary to receiving the vaccinations. She also reports red welts at the site of injections. She reports that the redness and welts continued to develop over several days and was the worse that they had been on 9/26/17. She states that the redness developed over the 2 injection sites which were in the same arm and about 1-2 inches apart. She states the redness is now at least 4 inches square. She was advised to use benadryl, ice packs and pain relievers to help with those symptom.. She was advised to continue to watch the redness on the arm and consult her primary care provider if anything changes for the worst.
Headache; severe arm pain; nausea; loss of appetite; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Sep2021 11:30 (Lot number: 3013584) at the age of 60 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "If covid prior vaccination: yes" (unspecified if ongoing). There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 06Sep2021, outcome "not recovered", described as "Headache"; PAIN IN EXTREMITY (non-serious) with onset 06Sep2021, outcome "not recovered", described as "severe arm pain"; NAUSEA (non-serious) with onset 06Sep2021, outcome "not recovered", described as "nausea"; DECREASED APPETITE (non-serious) with onset 06Sep2021, outcome "not recovered", described as "loss of appetite". Therapeutic measures were not taken as a result of headache, pain in extremity, nausea, decreased appetite.  Additional information: COVID prior vaccination was reported as yes. COVID tested post vaccination was reported as no. The patient had no known allergies. Headache every morning when waking up severe arm pain nausea loss of appetite.  Follow-up attempts are completed. No further information is expected.
Information has been received from a healthcare worker referring to multiple unspecified patients of unknown age and gender. Information about patients' concurrent conditions and medical history was not reported. On unknown dates the patients received doses of improperly stored (being exposed to temperatures outside of the recommended range) VAQTA (dose and route not reported, lot # L007559 with expiration date 01-JUN-2017). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Dizziness & HYPERtension Narrative: DIZZY; BP 166/90 MM HG; 149/84 MM HG; 150/86 MM HG
super sick; shingles; got the 1st shot Did not get the 2nd; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced sickness, shingles and incomplete course of vaccination. On an unknown date, the outcome of the sickness, shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the sickness and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The patient got the first shot. The patient did not get the second shot because he/she got super sick from the first shot, which led to incomplete course of vaccination. The patient informed that wasn't worth it to for him/her. The patient further stated that shingles were awful and the patient had them twice and he/she didn't want ever had them again. The follow-up would not possible as no contact details were available.
Patient fully vaccinated and died of covid related causes. According to patient's wife, patient was in critical care at the hospital and also had cancer. Patient's wife says they haven't went anywhere except for their oncology visit on 8/2. Patient died 13 days later after admitted to hospital.
Received vaccine 08-24 PM. C/O dizzy, faint, & headache 08/25. Improved by late afternoon, but still resting.
14 yo male presented with a 3 day history of chest pain after COVID-19 vaccine, found to have elevated Troponin level. Dx most likely myocarditis in the setting of recent COVID-19 vaccine. Patient was started on Ibuprofen 600 mg q6 hr scheduled. Troponin trended q6 hours with subsequent downtrending  of Troponins. (Highest troponin 5.03; most recent troponin 0.87 prior to discharge)
pt stated that she woke up w/ chills, body aches, flu like symptoms, entire body has muscle soreness , swelling and hot to ouch on the injection site, and swollen lymph nodes.
I tested positive for COVID-19 on 06DEC2022, I was feeling sick with a fever, headache and I was very fatigued. I called my doctor through a video visit and I was prescribed medication but it was not PAXLOVID it was molnupiravir. I started feeling better about 3 days after taking the medication.
A report was received from a health care professional on 11/14/03 concerning a 73 year old male vaccinee who inadvertently received expired Fluvirin SC on 11/10/03. On 11/10/03, the vaccinee inadvertently received expired Fluvirin SC. The vaccinee did not experience any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.